<DOC>
	<DOCNO>NCT01299675</DOCNO>
	<brief_summary>The purpose Post-Approval Study ( PAS ) demonstrate chronic performance SureScan pacing system use MRI environment accord product labeling . This study require Food Drug Administration ( FDA ) condition product approval .</brief_summary>
	<brief_title>SureScan Post-Approval Study</brief_title>
	<detailed_description />
	<mesh_term>Bradycardia</mesh_term>
	<criteria>1 . Subject legally authorized representative provide write authorization and/or consent per institution geographical requirement 2 . Subject intend implanted complete SureScan pacing system consist right atrial ventricular 5086MRI Lead ( use pace sense ) SureScan device 3 . Subject within 30 day implant ( maximum 50 % Chronic Performance Arm enrollment ) subject enrol Multiple MRI Scan Arm time MRI scan indication 1 . Subject , inaccessible followup 2 . Implant followup data , include adverse device effect system modification implant time enrollment unavailable 3 . Subject exclusion criterion require local law</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>MR conditional</keyword>
</DOC>